Viela Bio

Viela Bio

Viela Bio

Raised
$250M
Follow us
Alexa global traffic share
Latest funding
$250,000,000
Venture capital (Series A) - 2018
Boyu Capital Hillhouse Capital 6 Dimensions Capital +2
Team Size
1–10
Employees
Xconomy

Viela Bio Gets FDA Green Light for Rare Autoimmune Disease Treatment

FinSMEs

Viela Bio Launches With Up To $250M in Series A Financing

Health Funding
$250,000,000 Venture capital (Series A)
FierceBiotech

AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug